Gevo (NASDAQ:GEVO) Shares Up 0.6% - Still a Buy?

Gevo, Inc. (NASDAQ:GEVO - Get Free Report)'s stock price traded up 0.6% during mid-day trading on Tuesday . The company traded as high as $1.46 and last traded at $1.45. 908,857 shares changed hands during trading, a decline of 85% from the average session volume of 5,911,893 shares. The stock had previously closed at $1.44.

Analyst Ratings Changes

A number of brokerages have commented on GEVO. HC Wainwright restated a "buy" rating and issued a $14.00 target price on shares of Gevo in a research note on Wednesday, November 13th. UBS Group boosted their target price on shares of Gevo from $0.85 to $3.25 and gave the stock a "neutral" rating in a research report on Tuesday, October 22nd.

Gevo Trading Down 1.7 %

The company has a debt-to-equity ratio of 0.13, a current ratio of 8.25 and a quick ratio of 8.05. The firm has a market cap of $338.77 million, a P/E ratio of -4.26 and a beta of 2.94. The company's 50 day moving average is $1.89 and its two-hundred day moving average is $1.09.

Insider Buying and Selling at Gevo

In related news, insider Andrew Shafer sold 26,911 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $2.37, for a total transaction of $63,779.07. Following the completion of the transaction, the insider now owns 332,430 shares in the company, valued at $787,859.10. This trade represents a 7.49 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Christopher Michael Ryan sold 84,014 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $0.76, for a total value of $63,850.64. Following the transaction, the chief operating officer now owns 1,573,934 shares of the company's stock, valued at $1,196,189.84. This represents a 5.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 377,474 shares of company stock valued at $367,007 in the last 90 days. 4.00% of the stock is currently owned by company insiders.

Institutional Trading of Gevo

Several large investors have recently added to or reduced their stakes in GEVO. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Gevo in the first quarter valued at $89,000. BNP Paribas Financial Markets increased its position in Gevo by 79.5% in the 1st quarter. BNP Paribas Financial Markets now owns 142,679 shares of the energy company's stock valued at $110,000 after acquiring an additional 63,179 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Gevo by 3.1% in the first quarter. Vanguard Group Inc. now owns 13,805,071 shares of the energy company's stock worth $10,612,000 after acquiring an additional 409,693 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Gevo by 128.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 341,936 shares of the energy company's stock worth $263,000 after purchasing an additional 192,457 shares in the last quarter. Finally, Paloma Partners Management Co bought a new stake in shares of Gevo during the first quarter valued at approximately $74,000. 35.17% of the stock is owned by institutional investors.

Gevo Company Profile

Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.